C WorldWide Group’s Esperion Therapeutics ESPR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-4,874
Closed -$224K 117
2018
Q4
$224K Sell
4,874
-125
-3% -$6.02K ﹤0.01% 117
2018
Q3
$222K Buy
4,999
+695
+16% +$31.9K ﹤0.01% 126
2018
Q2
$169K Hold
4,304
﹤0.01% 126
2018
Q1
$311K Sell
4,304
-129
-3% -$9.47K ﹤0.01% 115
2017
Q4
$292K Sell
4,433
-579
-12% -$31.2K ﹤0.01% 113
2017
Q3
$251K Buy
5,012
+765
+18% +$36.9K ﹤0.01% 121
2017
Q2
$197K Sell
4,247
-353
-8% -$13K ﹤0.01% 121
2017
Q1
$162K Buy
+4,600
New +$105K ﹤0.01% 124
2016
Q4
Sell
-19,000
Closed -$263K 126
2016
Q3
$263K Hold
19,000
﹤0.01% 123
2016
Q2
$188K Hold
19,000
﹤0.01% 113
2016
Q1
$321K Hold
19,000
0.01% 116
2015
Q4
$423K Buy
19,000
+10,960
+136% +$277K 0.01% 127
2015
Q3
$190K Buy
8,040
+140
+2% +$8.79K ﹤0.01% 130
2015
Q2
$646K Buy
+7,900
New +$773K 0.01% 119

Other funds holding ESPR